ENTITY
Ascletis Pharma

Ascletis Pharma (1672 HK)

112
Analysis
Health Care • China
Ascletis Pharma is a fully integrated biotechnology company focused on the research, development, production, marketing, and sale of innovative pharmaceutical products. The company's marketed products include Ritonavir tablets, GANOVO®, and ASCLEVIR® for Hepatitis C, and it has a robust pipeline primarily in metabolic diseases, viral diseases, and oncology. Ascletis Pharma is headquartered in Hangzhou, China, and was founded in 2011.
more
bullish•Greentown China
•18 Mar 2020 12:38

Asia-Pac Stocks Priced For Liquidation

When investors are chucking in the towel, including the event space (RV, risk arb etc.), it's time for some old school perspective. In this...

Logo
917 Views
Share
bearish•Ascletis Pharma
•27 Feb 2020 10:09

SELL Ascletis Pharma: Why the COVID-19 Update Does Not Make Sense

We have previously discussed the short idea of Ascletis Pharma. After a few days of retreat, the stock reacted positively today to the news related...

Logo
501 Views
Share
•14 Feb 2020 17:32

HK - Shorts Pile Into Tencent, CCB, Ping An, Sunny Optical, AIA; Cover Mobile, China Tower, BYD

We take a look at the latest SFC data released today evening on short position reporting in Hong Kong for the week ended 7 February 2020.Total...

Logo
580 Views
Share
bearish•Ascletis Pharma
•13 Feb 2020 17:22

Ascletis Pharma: Reiterate Sell, 29% Downside

We have previously discussed the short idea of Ascletis Pharma. Today the stock reacted positively to the news that it received approval from the...

Logo
698 Views
Share
•07 Feb 2020 17:03

HK - Action in Anta, China Gas, Sunny Optical, Ascletis Pharma, Sa Sa, CMS

We take a look at the latest SFC data released today evening on short position reporting in Hong Kong for the week ended 31 January 2020.Total...

Logo
591 Views
Share
x